post

Volunteers required for collaborative research project

Myeloma UK is working with Janssen-Cilag Ltd. on a research project, investigating the views of patients with relapsed or refractory myeloma. The study is also looking to speak to family and friends of these patients.

Research news // 18th October 2018

  • We are looking to speak to people with myeloma who have had at least one line of treatment for myeloma, and whose myeloma has progressed following treatment (also known as relapsed or refractory myeloma)
  • We would also like to speak to family and friends who support someone with relapsed or refractory myeloma
  • We know that people with myeloma and their families can face difficult choices about treatment. We want to understand the views of people with relapsed or refractory myeloma and their families and friends, to inform future decisions about treatment and to learn about what treatment outcomes are important to them

 

If you would like to receive more information about this study, please contact:

Jayne Galinsky- Health Services Research Manager at Myeloma UK:

0131 557 3332 or Jayne.Galinsky@myeloma.org.uk

 

If you are interested in taking part in an interview, please contact:

Emily Boxell- Patient-centred Outcomes Project Manager at pH Associates:

01628 897 853 or PCO@phassociates.com

 

 

This research study is part of a series of collaborative projects between Myeloma UK and Janssen-Cilag Ltd. The study is organised and paid for by Janssen-Cilag Ltd, a pharmaceutical company who develop treatments for myeloma.